Inspira Technologies Oxy B.H.N. Ltd. is at the forefront of medical innovation, specializing in advanced oxygen delivery systems designed to enhance respiratory support for critically ill patients. With a strong commitment to improving patient outcomes, the company operates within the dynamic medical device sector, which is witnessing significant growth driven by escalating demand for effective respiratory therapies. Inspira's cutting-edge solutions address the evolving challenges in critical care, positioning the company as an attractive opportunity for institutional investors seeking to capitalize on the future of healthcare advancements.
| Revenue (TTM) | 289,000 |
| Gross Profit (TTM) | 2,000 |
| EBITDA | $-13.47M |
| Operating Margin | -4714.00% |
| Return on Equity | -397.90% |
| Return on Assets | -127.00% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.07 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $36.51M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |